Zhejiang Hisun Pharmaceutical Hits Day High with 9.98% Surge

Zhejiang Hisun Pharmaceutical Co., Ltd. has experienced significant activity today, with the stock rising by 9.98% as of July 20, 2026. The stock reached an intraday high of CNY 12.45, reflecting a strong performance compared to the broader market, as the China Shanghai Composite index only increased by 0.85% on the same day. Over the past week, Zhejiang Hisun has shown a remarkable gain of 9.89%, while the one-month performance stands at an impressive 26.4%. Year-to-date, the stock has surged by 25.88%, contrasting sharply with the China Shanghai Composite's decline of 4.35%. Despite a slight decrease of 0.32% over the past year, the company has demonstrated resilience with a notable profit increase of 631.2%. Financially, Zhejiang Hisun maintains a market capitalization of CNY 10,432 million and a price-to-earnings ratio of 14.00. The company also boasts a return on equity of 8.20% and a low debt-to-equity ratio of 0.05, indicating a stable financial position. With a dividend yield of 2.1%, the stock continues to attract attention in the pharmaceuticals and biotechnology sector.